AIM ImmunoTech Inc. AIM
0.16 USD 0.00 (+1.91%)
At closeNov 9, 2026, 6:05 AM EST
0.16 0.00 +0.06%
Pre-market · Nov 9, 6:05 AM ET
0.1476 Day range 0.1598
0.1476 52-week range 1.82
- YTD
- -85.91%
- 1 year
- -90.43%
News
marketbeat.com What Aimia (AIM) Said on Its Q3 Earnings Call Aimia TSE: AIM reported higher third-quarter revenue as its Cortland business benefited from price increases and improving demand in several markets, while a write-down on its Clear Media investment…
globenewswire.com AIM ImmunoTech Highlights Ampligen® Opportunity to Potentially Extend Benefits of RAS-Targeted Therapies in Pancreatic Cancer New investor presentation outlines scientific rationale for combining Ampligen's immune-stimulating activity with daraxonrasib's targeted RAS inhibition to potentially prolong clinical benefit